High flow oxygen supplementation during shock therapy
Phase 3
- Conditions
- Health Condition 1: F209- Schizophrenia, unspecified
- Registration Number
- CTRI/2021/09/036760
- Lead Sponsor
- IRB CMCVellore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
all patients between ages of 18 and 70 years posted for ECT whose relatives consent for the trial will be included
Exclusion Criteria
less than 18 years and >70 years will be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method lowest recorded oxygen saturation and time for recovery of saturation from lowest recorded to 95%Timepoint: immediately after termination of seizure.
- Secondary Outcome Measures
Name Time Method hemodynamic changes(heart rate,blood pressure) in relation to episodes of desaturation.Timepoint: immediately post termination of seizure at baseline, 10 mins and 30mins.